Paranuclear dot-like immunostaining for CD99: A unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas

American Journal of Surgical Pathology

Volumn 35, Issue 6, 2011, Pages 799-806

  Guo, Yan ^a   Yuan, Fei ^a   Deng, Huan ^a   Wang, Hua Feng ^a   Jin, Xiao Long ^a   Xiao, Jia Cheng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CD99; immunohistochemistry; pancreas; solid pseudopapillary neoplasm; tissue microarray

Indexed keywords

CD99 PROTEIN, HUMAN; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL NUCLEUS; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEUROECTODERM TUMOR; PANCREAS TUMOR; PANCREATOBLASTOMA; PAPILLARY CARCINOMA; TISSUE MICROARRAY;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, ACINAR CELL; CARCINOMA, PAPILLARY; CELL ADHESION MOLECULES; CELL NUCLEUS; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROECTODERMAL TUMORS, PRIMITIVE; PANCREATIC NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79958018122     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318219c036     Document Type: Article

References (49)

1. Abraham SC, Wu TT, Klimstra DS, et al. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposisassociated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol. 2001; 159:1619-1627. (Pubitemid 33062504)
2. Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol. 2002;160:1361-1369. (Pubitemid 34411640)
3. Abraham SC, Wu TT, Hruban RH, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/betacatenin pathway. Am J Pathol. 2002;160:953-962. (Pubitemid 34224584)
4. Ali A, Serra S, Asa SL, et al. The predictive value of CK19 and CD99 in pancreatic endocrine tumors. Am J Surg Pathol. 2006; 30:1588-1594. (Pubitemid 44808796)
5. Buxton D, Bacchi CE, Gualco G, et al. Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases. Am J Clin Pathol. 2009;131:574-579.
6. Chetty R, Serra S, Salahshor S, et al. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis. Hum Pathol. 2006;37: 212-217. (Pubitemid 43099842)
7. Chetty R, Jain D, Serra S. p120 catenin reduction and cytoplasmic relocalization leads to dysregulation of E-cadherin in solid pseudopapillary tumors of the pancreas. Am J Clin Pathol. 2008;130: 71-76.
8. Choi YL, Kim HS, Ahn G. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors. Arch Pathol Lab Med. 2000;124:563-569. (Pubitemid 30210989)
9. Choi YL, Chi JG, Suh YL. CD99 immunoreactivity in ependymoma. Appl Immunohistochem Mol Morphol. 2001;9:125-129. (Pubitemid 32477199)
10. de Saint Aubain Somerhausen N, Rubin BP, Fletcher CD. Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis. Mod Pathol. 1999;12:463-471. (Pubitemid 29230606)
11. Euscher ED, Deavers MT, Lopez-Terrada D, et al. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol. 2008;32:219-228. (Pubitemid 351172136)
12. Folpe AL, McKenney JK, Bridge JA, et al. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002;26:1175-1183. (Pubitemid 34969187)
13. Franz VK, ed. Tumors of the Pancreas. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1959:32-33.
14. Goodfellow PJ, Darling SM, Thomas NS, et al. A pseudoautosomal gene in man. Science. 1986;234:740-743. (Pubitemid 17184222)
15. Gordon MD, Corless C, Renshaw AA, et al. CD99, keratin, and vimentin staining of sex cord-stromal tumors, normal ovary, and testis. Mod Pathol. 1998;11:769-773. (Pubitemid 28381612)
16. Goto A, Niki T, Terado Y, et al. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs). Histopathology. 2004;45:384-392. (Pubitemid 39430643)
17. Hahn JH, Kim MK, Choi EY, et al. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol. 1997;159:2250-2258. (Pubitemid 127681015)
18. Hamilton G, Fellinger EJ, Schratter I, et al. Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen. Cancer Res. 1988;48:6127-6131.
19. Hartel PH, Fanburg-Smith JC, Frazier AA, et al. Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Mod Pathol. 2007;20:760-769. (Pubitemid 46933447)
20. Heitz P, Komminoth P, Perrin A, et al. Pancreatic endocrine tumors. In: DeLellis DA, Lloyd RV, Heitz PU et al, eds. World Health Organization Classification of Tumors Pathology and Genetics of Tumors of Endocrine Organs. Lyon: IARC Press; 2004:177-182.
21. Jung KC, Park WS, Bae YM, et al. Immunoreactivity of CD99 in stomach cancer. J Korean Med Sci. 2002;17:483-489.
22. Kallichanda N, Tsai S, Stabile BE, et al. Histogenesis of solid pseudopapillary tumor of the pancreas: the case for the centroacinar cell of origin. Exp Mol Pathol. 2006;81:101-107. (Pubitemid 44715791)
23. Kang LC, Dunphy CH. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes. Arch Pathol Lab Med. 2006;130:153-157. (Pubitemid 43237981)
24. Kim MJ, Jang SJ, Yu E. Loss of E-cadherin and cytoplasmicnuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas. Hum Pathol. 2008;39:251-258.
25. Klimstra DS, Wenig BM, Heffess CS. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Semin Diagn Pathol. 2000;17:66-80. (Pubitemid 30132100)
26. Kloppel G, Luttges J, Klimstra D, et al. Solid-paeudopapillary neoplasm. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press; 1999:246-248.
27. Kommoss F, Oliva E, Bittinger F, et al. Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome. Hum Pathol. 2000;31:1055-1061.
28. KosmahlM, Seada LS, Janig U, et al. Solid-pseudopapillary tumor of the pancreas: its origin revisited. Virchows Arch. 2000;436:473-480. (Pubitemid 30312163)
29. Lee JH, Kim SH, Wang LH, et al. Clinical significance of CD99 down-regulation in gastric adenocarcinoma. Clin Cancer Res. 2007;13:2584-2591.
30. Machen SK, Fisher C, Gautam RS, et al. Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumour. Histopathology. 1998;33:501-507. (Pubitemid 28563374)
31. Mahfouz S, Aziz AA, Gabal SM, et al. Immunohistochemical study of CD99 and EMA expression in ependymomas. Medscape J Med. 2008;10:41.
32. Maitra A, Weinberg AG, Schneider N, et al. Detection of t(11;22)(q24;q12) translocation and EWS-FLI-1 fusion transcript in a case of solid pseudopapillary tumor of the pancreas. Pediatr Dev Pathol. 2000;3:603-605.
33. Matias-Guiu X, Pons C, Prat J. Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol. 1998;29:840-845. (Pubitemid 28375991)
34. Milanezi F, Pereira EM, Ferreira FV, et al. CD99/MIC-2 surface protein expression in breast carcinomas. Histopathology. 2001;39: 578-583. (Pubitemid 34017130)
35. Monteagudo C, Calduch L, Navarro S, et al. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol. 2002;117:126-131. (Pubitemid 34052482)
36. Notohara K, Hamazaki S, Tsukayama C, et al. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol. 2000;24: 1361-1371.
37. Pelosi G, Fraggetta F, Sonzogni A, et al. CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours. Virchows Arch. 2000;437:270-274.
38. Riopel M, Dickman PS, Link MP, et al. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol. 1994;25:396-399. (Pubitemid 24151126)
39. Robertson PB, Neiman RS, Worapongpaiboon S, et al. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity. Mod Pathol. 1997;10:277-282. (Pubitemid 27228873)
40. Stommer P, Kraus J, Stolte M, et al. Solid and cystic pancreatic tumors: clinical, histochemical, and electron microscopic features in ten cases. Cancer. 1991;67:1635-1641.
41. Tanaka Y, Kato K, Notohara K, et al. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solidpseudopapillary neoplasm. Cancer Res. 2001;61:8401-8404. (Pubitemid 33131114)
42. Tang LH, Aydin H, Brennan MF, et al. Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol. 2005;29:512-519. (Pubitemid 40411185)
43. Tang WW, Stelter AA, French S, et al. Loss of cell-adhesion molecule complexes in solid pseudopapillary tumor of pancreas. Mod Pathol. 2007;20:509-513. (Pubitemid 46631992)
44. Tiemann K, Kosmahl M, Ohlendorf J, et al. Solid pseudopapillary neoplasms of the pancreas are associated with FLI-1 expression, but not with EWS/FLI-1 translocation. Mod Pathol. 2006;19:1409-1413. (Pubitemid 44624158)
45. Viale G, Doglioni C, Gambacorta M, et al. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin. Cancer. 1992; 70:2268-2277.
46. Waclavicek M, Majdic O, Stulnig T, et al. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol. 1998;161:4671-4678. (Pubitemid 28492041)
47. Wilkerson AE, Glasgow MA, Hiatt KM. Immunoreactivity of CD99 in invasive malignant melanoma. J Cutan Pathol. 2006;33: 663-666. (Pubitemid 44536345)
48. Xuan Y, Kim S, Lin Z. Protein expression and gene promoter hypermethylation of CD99 in transitional cell carcinoma of urinary bladder. J Cancer Res Clin Oncol. 2011;137:49-54.
49. Zhang PJ, Barcos M, Stewart CC, et al. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases. Mod Pathol. 2000;13:452-458. (Pubitemid 30225236)